USPTO serial 79310835
EITAN MEDICAL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 1, 2022
- Examiner
- SOUDERS, MICHAEL J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EITAN MEDICAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Avital (Tally) Eitan
Avital (Tally) Eitan GORNITZKY & CO.6480 Calverton Drive, Unit 202Tally Eitan c/o Edna EisemmanFrederick, MD 20874Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical, veterinary and surgical apparatus and instruments, namely, infusion and injection devices for administering fluid, drugs and nutrition and parts and accessories for use with these instruments; Drug delivery devices and their compatible disposables, sold empty, namely, syringes, infusion sets, filling bags, cartridges, administration sets, connectors, tubing, cassettes, pumping connectors, valves, filters for carrying and delivering pharmaceuticals, fluids, drugs and nutrition for medical treatment with integrated recorded software for monitoring, tracking, gathering, transmitting, controlling, processing, measuring and managing data regarding the delivery of pharmaceuticals, drugs, fluids and nutrition into the patient, the performance of the medical delivery devices, the patient's behavior, reaction to, consumption and effectiveness of the pharmaceuticals, drugs, fluids and nutrition provided to the patient via medical delivery devices, sold as a unit therewith; drug delivery devices sold empty, namely, catheters, pen needles, injection needles, syringes, patches, infusion pumps, patch pumps, wearable injectors, and handheld injectors; medical syringes infusion sets; lancets; lancing devices for delivering medication; apparatus delivering pharmaceuticals, namely, medical pumps and injectors; infusion bolus handle for external patient's activation of the pump; infusion pumps cradles for mounting of infusion pumps, carrying and locking infusion pumps; infusion lock boxes for mounting of infusion pumps, carrying and locking infusion pumps | ACTIVE | — |
| 042 | Computer system design for monitoring, tracking, gathering, transmitting, controlling, processing, measuring and managing data regarding the delivery of pharmaceuticals, drugs, fluids and nutrition into the patient; software as a service [SaaS] services featuring software for monitoring, tracking, gathering, transmitting, controlling, processing, measuring and managing data regarding the delivery of pharmaceuticals, drugs, fluids and nutrition into the patient; platform as a service [PaaS] featuring computer software platforms for monitoring, tracking, gathering, transmitting, controlling, processing, measuring and managing data regarding the delivery of pharmaceuticals, drugs, fluids and nutrition into the patient; computer system design for monitoring, tracking, gathering, transmitting, controlling, processing, measuring and managing data regarding the performance of the medical delivery devices of pharmaceuticals, drugs, fluids and nutrition; software as a service [SaaS] services featuring software for monitoring, tracking, gathering, transmitting, controlling, processing, measuring and managing data regarding the performance of the medical delivery devices of pharmaceuticals, drugs, fluids and nutrition; platform as a service [PaaS] featuring computer software platforms for monitoring, tracking, gathering, transmitting, controlling, processing, measuring and managing data regarding the performance of the medical delivery devices of pharmaceuticals, drugs, fluids and nutrition; computer system design for monitoring, tracking, gathering, transmitting, controlling, processing, measuring and managing data regarding the patient's behavior, reaction to, consumption and effectiveness of the pharmaceuticals, drugs, fluids and nutrition provided to the patient via medical delivery devices; software as a service [SaaS] services featuring software for monitoring, tracking, gathering, transmitting, controlling, processing, measuring and managing data regarding the patient's behavior, reaction to, consumption and effectiveness of the pharmaceuticals, drugs, fluids and nutrition provided to the patient via medical delivery devices; platform as a service [PaaS] featuring computer software platforms for monitoring, tracking, gathering, transmitting, controlling, processing, measuring and managing data regarding the patient's behavior, reaction to, consumption and effectiveness of the pharmaceuticals, drugs, fluids and nutrition provided to the patient via medical delivery devices; computer system design for use in medical delivery devices; software as a service [SaaS] services featuring software for use in medical delivery devices; platform as a service [PaaS] featuring computer software platforms for use with medical delivery devices | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Eitan Medical Ltd
- Other trademarks owned by Eitan Medical Ltd
- Other trademarks owned by Eitan Medical Ltd
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named EITAN MEDICAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 12, 2024 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Feb 12, 2024 | RHRD | RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED | — |
| Mar 14, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 22, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 22, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 1, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 7, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 1, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 1, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 19, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 19, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 23, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 16, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 16, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 27, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 27, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 27, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 11, 2022 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 10, 2022 | ALIE | ASSIGNED TO LIE | — |
| Jul 7, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 7, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 7, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 7, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 7, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 7, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 7, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 7, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 7, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 6, 2022 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jun 21, 2022 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jun 20, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 8, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 7, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 7, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 7, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 12, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 12, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 12, 2022 | ALIE | ASSIGNED TO LIE | — |
| May 10, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 9, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 9, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 9, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 30, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 30, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 27, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 25, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 30, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 30, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 16, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 15, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 9, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 22, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 18, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 13, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |